| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Senti Biosciences Holdings, Inc.
13D/A
Amendment 6
SNTI · 816944102
|
54.6% |
9/11/2026
Event 9/3/2026
|
|||
| Celadon Partners SPV 24 | 54.6% | ||||
| Celadon Partners, LLC | 54.6% | ||||
| CPIF II-7 Limited | 54.6% | ||||
|
Senti Biosciences Holdings, Inc.
13D/A
Amendment 5
SNTI · 816944102
|
54.6% |
7/16/2026
Event 7/14/2026
|
|||
| Celadon Partners SPV 24 | 54.6% | ||||
| Celadon Partners, LLC | 54.6% | ||||
| CPIF II-7 Limited | 54.6% | ||||
|
Senti Biosciences, Inc.
13D/A
Amendment 4
SNTI · 816944102
|
54.6% |
5/4/2026
Event 4/27/2026
|
|||
| Celadon Partners SPV 24 | 54.6% | ||||
| Celadon Partners, LLC | 54.6% | ||||
| CPIF II-7 Limited | 54.6% | ||||
|
Senti Biosciences, Inc.
13D/A
Amendment 3
SNTI · 81726A209
|
45.0% |
1/20/2026
Event 1/19/2026
|
|||
| Celadon Partners SPV 24 | 45.0% | ||||
| Celadon Partners, LLC | 45.0% | ||||
|
Senti Biosciences, Inc.
13D/A
Amendment 2
SNTI · 81726A209
|
45.0% |
9/2/2025
Event 8/29/2025
|
|||
| Celadon Partners SPV 24 | 45.0% | ||||
| Celadon Partners, LLC | 45.0% | ||||
|
Senti Biosciences, Inc.
13D/A
Amendment 1
SNTI · 81726A209
|
37.6% |
3/17/2025
Event 3/6/2025
|
|||
| Celadon Partners SPV 24 | 37.6% | ||||
| Celadon Partners, LLC | 37.6% | ||||
|
Senti Biosciences, Inc.
13D
SNTI · 81726A209
|
37.6% |
3/13/2025
Event 3/6/2025
|
|||
| Celadon Partners SPV 24 | 37.6% | ||||
| Celadon Partners, LLC | 37.6% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.